| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -7,102,455 | -9,523,835 | ||
| Series a preferred cash dividend | 2,089 | 2,089 | ||
| Net loss attributable to common stockholders | -7,104,544 | -9,525,924 | ||
| Earnings per share, basic | -0.14 | -0.21 | ||
| Earnings per share, diluted | -0.14 | -0.21 | ||
| Weighted average number of shares outstanding, basic | 50,666,430 | 44,555,095 | ||
| Weighted average number of shares outstanding, diluted | 50,666,430 | 44,555,095 | ||
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)